Axel Stang

Summary

Affiliation: Asklepios Katharina Schroth Spinal Deformities Rehabilitation Centre
Country: Germany

Publications

  1. ncbi request reprint Selection criteria for radiofrequency ablation for colorectal liver metastases in the era of effective systemic therapy: a clinical score based proposal
    Axel Stang
    Department of Hematology and Oncology, Asklepios Hospital Barmbek, Rübenkamp 220, 22291 Hamburg, Germany
    BMC Cancer 14:500. 2014
  2. doi request reprint A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases
    Axel Stang
    Department of Oncology, Asklepios Hospital Hamburg Altona, Germany
    Eur J Cancer 45:1748-56. 2009
  3. doi request reprint Differentiation of benign from malignant focal splenic lesions using sulfur hexafluoride-filled microbubble contrast-enhanced pulse-inversion sonography
    Axel Stang
    Department of Hematology and Oncology, Asklepios Klinik Altona, Paul Ehrlich Strasse 1, D 22763 Hamburg, Germany
    AJR Am J Roentgenol 193:709-21. 2009
  4. doi request reprint Real-time ultrasonography-computed tomography fusion imaging for staging of hepatic metastatic involvement in patients with colorectal cancer: initial results from comparison to US seeing separate CT images and to multidetector-row CT alone
    Axel Stang
    Department of Oncology, Asklepios Hospital Altona, Hamburg, Germany
    Invest Radiol 45:491-501. 2010
  5. doi request reprint Incidentally detected splenic lesions in ultrasound: does contrast-enhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma from malignant lesions?
    A Stang
    Department of Hematology, Oncology, and Palliative Care, Asklepios Hospital Barmbek, Hamburg, Germany
    Ultraschall Med 32:582-92. 2011

Detail Information

Publications5

  1. ncbi request reprint Selection criteria for radiofrequency ablation for colorectal liver metastases in the era of effective systemic therapy: a clinical score based proposal
    Axel Stang
    Department of Hematology and Oncology, Asklepios Hospital Barmbek, Rübenkamp 220, 22291 Hamburg, Germany
    BMC Cancer 14:500. 2014
    ..We aimed to define selection criteria for patients with liver-limited CLM who may benefit from adding RFA to systemic therapy with respect to long-term disease control...
  2. doi request reprint A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases
    Axel Stang
    Department of Oncology, Asklepios Hospital Hamburg Altona, Germany
    Eur J Cancer 45:1748-56. 2009
    ..To evaluate the role of radiofrequency ablation (RFA) as treatment of colorectal cancer liver metastases (CLMs)...
  3. doi request reprint Differentiation of benign from malignant focal splenic lesions using sulfur hexafluoride-filled microbubble contrast-enhanced pulse-inversion sonography
    Axel Stang
    Department of Hematology and Oncology, Asklepios Klinik Altona, Paul Ehrlich Strasse 1, D 22763 Hamburg, Germany
    AJR Am J Roentgenol 193:709-21. 2009
    ..The purpose of our study was to evaluate whether sonographic characterization of focal splenic lesions could be improved by using low mechanical index pulse-inversion sonography after sulfur hexafluoride-filled microbubble injection...
  4. doi request reprint Real-time ultrasonography-computed tomography fusion imaging for staging of hepatic metastatic involvement in patients with colorectal cancer: initial results from comparison to US seeing separate CT images and to multidetector-row CT alone
    Axel Stang
    Department of Oncology, Asklepios Hospital Altona, Hamburg, Germany
    Invest Radiol 45:491-501. 2010
    ....
  5. doi request reprint Incidentally detected splenic lesions in ultrasound: does contrast-enhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma from malignant lesions?
    A Stang
    Department of Hematology, Oncology, and Palliative Care, Asklepios Hospital Barmbek, Hamburg, Germany
    Ultraschall Med 32:582-92. 2011
    ..The aim of the study was to identify and validate enhancing features for differentiating benign vascular neoplasms of the hemangioma/hamartoma type from malignant splenic lesions on contrast-enhanced ultrasonography (CEUS)...